Abiopharma

News list

Wortendyke Jason 🟡 adjusted position in 1.3K shares (2 derivative) of SharkNinja, Inc. (SN) Transaction Date: Jun 18, 2026 | Filing ID: 000297

Full text

News bot June 22, 2026, 8:44 p.m.
🔍 Wortendyke Jason (Executive)

Company: SharkNinja, Inc. (SN)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 2,064
- Total shares sold: 726
Detailed Transactions and Holdings:
- Acquired 726 shares of Ordinary Shares (Direct)
  Date: 2026-06-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 726.00 | transaction_form_type: 4
- Sold 726 shares of Restricted Share Units (Derivative)
  Date: 2026-06-18 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
- Acquired 1,338 shares of Restricted Share Units (Derivative)
  Date: 2026-06-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,338.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Each Restricted Share Unit represents the contingent right to receive one ordinary share.
- F2: These Restricted Share Units were granted on January 5, 2026 and vested in full on June 18, 2026.
- F3: These Restricted Share Units were granted on June 18, 2026, and vest in full on the earlier of (i) SharkNinja, Inc.'s annual general meeting of shareholders following the grant date or (ii) the first anniversary of the grant date (i.e., June 18, 2027), subject to continued service.